Cargando…
Incorporating Molecular Tools into Early-Stage Clinical Trials
The author discusses the implications of a new phase I trial investigating the role of rapamycin in patients with glioblastoma.
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211557/ https://www.ncbi.nlm.nih.gov/pubmed/18215108 http://dx.doi.org/10.1371/journal.pmed.0050021 |